Asymptomatic intracranial hemorrhage in a newborn with congenital factor VII deficiency and successful treatment with recombinant activated factor VII
Intracranial hemorrhage is considered the most common cause of death in newborns with congenital factor VII (FVII) deficiency. Recombinant activated FVII (rFVIIa) provides specific replacement therapy, however there is limited experience with its neonatal use. We describe our experience about the t...
Saved in:
| Main Authors: | Zeynep İnce, Özgül Bulut, Melike Tuğrul-Aksakal, Ayşegül Ünüvar, Ömer Devecioğlu, Asuman Çoban |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
2018-10-01
|
| Series: | The Turkish Journal of Pediatrics |
| Subjects: | |
| Online Access: | https://turkjpediatr.org/article/view/903 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE EFFICACY OF RECOMBINANT ACTIVATED FACTOR VII (COAGIL VII) FOR TREATMENT HAEMORRHAGE AND HAEMOSTASIS DISORDES DURING THORACIC AORTA OPERATIONS
by: N. A. TREKOVA, et al.
Published: (2019-07-01) -
Establishment of a method for detecting the potency of recombinant human coagulation factor Ⅶa for injection
by: WU Rong, et al.
Published: (2025-03-01) -
Acute myeloid leukemia: A rare cause of acquired isolated factor VII deficiency
by: Zaineb Mlayah, et al.
Published: (2025-01-01) -
The features of the mode of delivery in patients with congenital deficiency of coagulation factor VII: case reports
by: A. Yu. Bulanov, et al.
Published: (2020-12-01) -
Analysis of the effect of initial hemostasis resuscitation with recombinant human coagulation factor VII a on the treatment of postoperative hemorrhage in cardiac surgery
by: Yan Yu, et al.
Published: (2025-01-01)